ERCC1 Gene Cerebrooculofacioskeletal Syndrome Type 4 NGS Genetic DNA Test
Introduction to the ERCC1 Gene Test
The ERCC1 Gene Cerebrooculofacioskeletal Syndrome Type 4 NGS Genetic DNA Test is a specialized diagnostic tool designed to identify genetic anomalies associated with dysmorphology. This test plays a crucial role in understanding the genetic underpinnings of cerebrooculofacioskeletal syndrome, enabling healthcare providers to offer tailored management and treatment options.
What the Test Measures
This genetic test utilizes Next-Generation Sequencing (NGS) technology to analyze the ERCC1 gene, which is vital for DNA repair mechanisms. By detecting mutations or alterations in this gene, the test can confirm or rule out the presence of cerebrooculofacioskeletal syndrome type 4.
Who Should Consider This Test?
Individuals exhibiting symptoms such as:
- Facial dysmorphisms
- Ocular abnormalities
- Skeletal malformations
Additionally, those with a family history of genetic disorders or who have undergone genetic counseling may find this test beneficial.
Benefits of Taking the Test
- Provides clarity on genetic health and risks.
- Facilitates informed decision-making regarding treatment options.
- Helps in understanding potential hereditary implications for family members.
- Enables early intervention and management strategies.
Understanding Your Results
Results from the ERCC1 Gene test will typically be available within 3 to 4 weeks. A genetic counselor will assist in interpreting the results, providing guidance on the implications for health and family planning.
Test Pricing
| Price Type | Amount (KSh) |
|---|---|
| Discount Price | 40,000 |
| Regular Price | 56,000 |
Book Your Test Today!
We have branches across all major cities in Kenya and offer a convenient home sample collection service. Don’t wait to gain insights into your genetic health. Contact us to book the ERCC1 Gene Cerebrooculofacioskeletal Syndrome Type 4 NGS Genetic DNA Test today! Call or WhatsApp us at +254711564616.
